|
0
|
|
Conditional activation of Cas13 enforces lysogeny in a native type VI-A CRISPR host.
(nature.com)
|
Godsil M
…
Meeske AJ
Nature Microbiology
2026-04-01
|
#immunity
#crispr
#phage
|
|
0
|
|
In vivo site-specific engineering to reprogram T cells.
(nature.com)
|
Nyberg WA
…
Eyquem J
Nature
2026-04-01
|
#cancer
#immunotherapy
#crispr
#gene therapy
#genome editing
|
|
0
|
|
High-content CRISPR activation screens identify synthetically lethal RNA-based mechanisms to sensitize cancer cells to targeted T cell cytotoxicity.
(nature.com)
|
Akana RV
…
Jerby L
Nature Genetics
2026-04-01
|
#transcriptomics
#cancer
#screening
#immunotherapy
#crispr
|
|
0
|
|
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase.
(nature.com)
|
Wu Y
…
Tang W
Nature Biotechnology
2026-04-01
|
#crispr
#gene therapy
#mutagenesis
#directed evolution
|
|
0
|
|
A multi-kingdom genetic barcoding system for precise clone isolation.
(nature.com)
|
Ishiguro S
…
Yachie N
Nature Biotechnology
2026-04-01
|
#transcriptomics
#crispr
#barcoding
#cloning
|
|
0
|
|
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours.
(nature.com)
|
Yang L
…
Chen S
Nature
2026-04-01
|
#cancer
#immunotherapy
#crispr
#engineering
#cytotoxicity
|